Science Explorer Back to mapMap
Discussion
Researcher · Metaxa Hospital · Greece

N. Karvounis

N. Karvounis publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology and Lung Cancer Research Studies.

OpenAlex
World rank
#7,037,930
of 7,710,434 ranked researchers
Rank in Greece
#31,614
of 33,280
Works
30
Citations
360
Citations per work
12.0
h-index
10
i10-index 10Top 59% in Oncology
N. Karvounis

What does N. Karvounis research?

N. Karvounis's work is mostly in Medicine (70%), Biochemistry, Genetics and Molecular Biology (12%).

Health Sciences: 21 works · 69.5% of their workMedicine: 21 works · 69.5% of their workOncology: 9 works · 29.3% of their workSurgery: 6 works · 20.7% of their workPulmonary and Respiratory Medicine: 4 works · 13.4% of their workPathology and Forensic Medicine: 2 works · 6.1% of their workEverything else: 5 works · 18.3% of their workLife Sciences: 4 works · 12.2% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 12.2% of their workCancer Research: 2 works · 7.3% of their workMolecular Biology: 1 works · 4.9% of their workTHEIR WORKN. Karvounis30works
Life Sciences12%Health Sciences70%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2169.5%
  2. Everything else518.3%
    1. Biochemistry, Genetics and Molecular Biology412.2%
  1. 1Oncology29% of their works
  2. 2Surgery21% of their works
  3. 3Pulmonary and Respiratory Medicine13% of their works
  4. 4Cancer Research7% of their works
  5. 5Pathology and Forensic Medicine6% of their works
  6. 6Molecular Biology5% of their works

Research topics

Which keywords describe N. Karvounis's research?

The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, Immunotherapy, Molecular Subtypes, Neoadjuvant Therapy, ALK Inhibitors and EGFR Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Chemotherapy205 topics
  2. Clinical Trials112 topics
  3. Targeted Therapy112 topics
  4. Immunotherapy92 topics
  5. Molecular Subtypes82 topics
  6. Neoadjuvant Therapy82 topics
  7. ALK Inhibitors61 topic
  8. EGFR Mutations61 topic
  9. Chemotherapy-Induced Peripheral Neuropathy51 topic
  10. Genomic Profiles51 topic
  11. Small-Cell Lung Cancer51 topic
  12. Taxanes51 topic
  13. Bladder Cancer41 topic
  14. Breast Tumours41 topic
  15. Cetuximab41 topic
  16. DNA41 topic
  17. Gene Expression41 topic
  18. KRAS Mutations41 topic
  19. Topoisomerases41 topic
  20. Urothelial Carcinoma41 topic
  21. Cisplatin31 topic
  22. Nephrotoxicity31 topic

Where does N. Karvounis work?

N. Karvounis's main affiliation in the publication record is Metaxa Hospital, Greece.

How many publications and citations does N. Karvounis have?

OpenAlex counts 30 works and 360 citations for N. Karvounis, an h-index of 10, ranking #7,037,930 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about N. Karvounis. Posts are plain text and can be reported.